systems. Rogida Medical emphasizes low-contaminant production by avoiding animal-derived inputs and managing microclimate and waste in a controlled way. Its team develops cannabis genetics and strain selection tailored to medical applications, supported by tissue culture cloning and research into plant science. Rogida Medical positions its output for regulated medical cannabis markets and pharmaceutical supply chains that require consistent quality and compliant production processes.